Graviton

New York, United States

Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases.

$39.8M raised

Feb 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Graviton raised?

Graviton has raised $39.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.

Who are Graviton's investors?

Graviton's investors include Sanofi.

Where is Graviton headquartered?

Graviton is headquartered in New York, United States.

What does Graviton do?

Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases.

What stage is Graviton at?

Graviton is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 1, 2024.

MLA

"Graviton — Funding & Investors." VCBacked, February 1, 2024, https://www.vcbacked.co/company/graviton. Accessed July 2, 2026.

APA

VCBacked. (2024). Graviton — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/graviton

Wikipedia (cite web)

{{cite web |title=Graviton — Funding & Investors |url=https://www.vcbacked.co/company/graviton |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 1, 2024.